Member Info for AquaeSulis01

Yes every time they grant an exclusive territory

Sounds like Opti will use the money to ramp up the sales; this from TW

"OptiBiotix Health (OPTI) has announced a “Commercial strategy update” which shows strong progress in its strategy to initially build sales and brand presence and then move up the value chain by selling more product than ingredients and commercialising further compounds. We’ve also had a catch up chat with CEO Steve O’Hara. This should be THE YEAR when profits come close to or exceed £1 million."

Ceres Power says its 'right time to grow into world class player' after completing £181m fundraise

https://www.proactiveinvestors.co.uk/companies/news/944253/ceres-power-says-its--right-time-to-grow-into-world-class-player--after-completing-181m-fundraise-944253.html

It's not small beer but as the finnces seem healthy some explanation from the company over what they intend to do with the money would be welcome. i.e. What prompted the extraordinary approach to breach the lock-in agreement "s at 13 October 2020, the Company's major shareholder, Optibiotix Health Plc ("Optibiotix"), holds 38,138,569 Ordinary Shares representing 29.8 per cent. of the Company's issued share capital. Optibiotix, Cenkos and the Company have entered into a lock-in and orderly market agreement pursuant to which Optibiotix has undertaken to the Company and to Cenkos that: (i) it will not until the first anniversary of the Fundraising dispose of the Ordinary Shares that it holds during such period; and (ii) it will only dispose of such Ordinary Shares during the 12 month period following such first anniversary through Cenkos (or its replacement) so as to ensure an orderly market in the Shares."

Skinbio RNS announcing an opti share selloff despite the agreement with Cenkos; will they pay a dividend to holders here?

With Opti now selling despite the lock in agreement makes you wonder what the point of the agreement was in the first place as appears to have no legal basis at all.

Seneca own 16m shares they'll be finished once their portfolio is re-balanced and neither you or I know when that will be but it is irrelevant as other iis are starting to step in and will continue to do so as the story unfolds.

Perhaps SOH should push out a statement that he is investigating the use of blockchain in the probiotic market, after all it seems to have worked for wildcat which has gone from a market cap of £8M to £91M in less than 3 months and they have produced and have in the pipeline absolutely nothing

"The Board of Wildcat, the LSE listed Company targeting investment opportunities in businesses and assets within the upstream sector of the petroleum industry and exploring the implementation of blockchain technology within the sector, notes the recent rise in the Company's share price and want to confirm that they are not aware of any specific reason for this significant increase, nor is it aware of any material developments beyond those previously notified to the market.
The Company's Directors are continuing to focus on sourcing an appropriate target for Wildcat to acquire and continuing to explore the implementation of blockchain technology within the sector. While the Board remains optimistic that these opportunities can be converted into meaningful developments, at present no assurances can be provided that the effort will be successful."

Just noting the significant Weichai fund raise contribution has yet to be rubber stamped by the Chinese Govt.

On a brighter note the Reach RNS re the Doosan MOU looks good and in today's Telegraph re getting Industry to go green

https://www.telegraph.co.uk/business/2021/03/18/getting-industry-go-green-will-not-come-cheaply/

"Instead it details where previously announced funding will be put to work in areas such as eco-friendly heatpumps and insulation in buildings, research into making steel from clean hydrogen and directing business to swap to renewable power and adopt carbon capture technology"

JOHN admire your optimism but with a 10% share dilution as well as the discount offer I am bracing myself for an initial 20% fall and if it proves to be not so severe then so much the better. Like you I have added in recent times so timing not great but at least the reason for the placing is positive as is the fact that both Weichai and Bosch are increasing their holdings.

You think staycations around the UK are a good thing? As a previous P&O Cruise regular I was looking forward to the advertised upcoming UK Cruises but having received the email today only to discover that as a double vaccinated only passenger I would not be permitted to visit any of the destinations in my own Country; well no thanks

Mr Johnson underlined this in the Commons this lunchtime, telling MPs: “There is no question that China will pose a great challenge for an open society such as ours.

“But we will also work with China where that is consistent with our values and interests, including building a stronger and positive economic relationship and in addressing climate change.

Augers well for Ceres Weichai partnership

True Larus but it can take an unusually long time for the penny to drop in some cases; just look at the Skinbio price languishing at 15p Mid December despite all knowing then about the potential impact of the planned axis trial and skinbiotix launch courtesy of interviews with Share Prophets and Elrico's podcast with Stuart

Very special Mathurin. They found that skinbiotix increases the skin elasticity whilst trialling for other properties; worth a watch of the Share Prophets interview with Stuart last May where he explains exactly why it attracted the attention of Croda.

https://www.skinbiotherapeutics.com/articles/

The mix of 6 probiotics used has been subject to patent application

Fantastic update, the progress made on sweetbiotix is very encouraging and the extension into France for Cholbiome in response to customer interest is also potentially significant. LPLDL as a drug biotherapeutic as an alternative to statins obce through trials will be huge; happy days

We were told in the recent trade update that overall costs are reducing whilst at the same time margins and sales are increasing so what is the fascination with individual salaries and appointments?
"Total invoiced sales for the Group were £1,513,089 (2019: £744,833), an increase of 103% on the previous year. Administrative expenses (excluding non-cash items such as share based payments and amortisation) were £1,592,320 (2019: £2,204,216), a reduction of £530,350 (27.8%) on the previous year. As the Company scales its sales, it is starting to see an improvement in margins, increasing from 53% in 2019 to 58% in 2020. The Company is now in a strong position with increasing sales and improving margins complemented by a large reduction in costs, demonstrating the scalability of the business model."

Brilliant interview out sounds very excited about Molopo

https://twitter.com/PowerMetRes/status/1371852511842336771?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

To be fair belgrano you could have bought as many as you like as a pi at less than the 16p offer price shortly thereafter

Big seller confirmed as Seneca who are not locked in